RETA
Allianz Asset Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-7,300
| Closed | -$744K | – | 1766 |
|
2023
Q2 | $744K | Hold |
7,300
| – | – | ﹤0.01% | 1227 |
|
2023
Q1 | $664K | Buy |
+7,300
| New | +$664K | ﹤0.01% | 1362 |
|
2022
Q1 | – | Sell |
-9,030
| Closed | -$238K | – | 2158 |
|
2021
Q4 | $238K | Sell |
9,030
-2,000
| -18% | -$52.7K | ﹤0.01% | 1990 |
|
2021
Q3 | $1.11M | Hold |
11,030
| – | – | ﹤0.01% | 1527 |
|
2021
Q2 | $1.56M | Sell |
11,030
-300
| -3% | -$42.5K | ﹤0.01% | 1365 |
|
2021
Q1 | $1.13M | Hold |
11,330
| – | – | ﹤0.01% | 1424 |
|
2020
Q4 | $1.4M | Buy |
11,330
+2,300
| +25% | +$284K | ﹤0.01% | 1384 |
|
2020
Q3 | $880K | Sell |
9,030
-21,753
| -71% | -$2.12M | ﹤0.01% | 1440 |
|
2020
Q2 | $4.8M | Buy |
30,783
+8,354
| +37% | +$1.3M | 0.01% | 1021 |
|
2020
Q1 | $3.24M | Buy |
22,429
+6,178
| +38% | +$892K | ﹤0.01% | 1124 |
|
2019
Q4 | $3.32M | Buy |
+16,251
| New | +$3.32M | ﹤0.01% | 1310 |
|